Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
KOSTEN, THOMAS
One or more keywords matched the following items that are connected to KOSTEN, THOMAS
Item TypeName
Academic Article Genetics of dopamine and its contribution to cocaine addiction.
Academic Article Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population.
Academic Article Epigenetics of drug abuse: predisposition or response.
Academic Article Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy.
Academic Article Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.
Academic Article The potential of pharmacogenomics to treat drug addiction.
Academic Article Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
Academic Article ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
Concept Pharmacogenetics
Academic Article Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
Academic Article The influence of dopamine ?-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study.
Academic Article Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy.
Academic Article Pharmacogenetics of Dopamine ?-Hydroxylase in cocaine dependence therapy with doxazosin.
Grant Comorbidity in Cocaine and Opioid Pharmacotherapy
Academic Article Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction.
Academic Article Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant.
Academic Article A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-na?ve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms.
Search Criteria
  • Pharmacogenetics